Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 1/20 | 0.59 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.59 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.59 |
| ▸ | FADS1 | O60427 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.50 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | STK39 | Q9UEW8 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | GRM5 | P41594 | 1/20 | 0.49 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8672680 | 0.81 | PTGS1 (0.71) | P2RX1P2RX4P2RX7FADS1SMN1; SMN2 | |
| SCHEMBL15778718 | 0.76 | FADS1 (0.74) | P2RX1P2RX4P2RX7FADS1SMN1; SMN2 | |
| SCHEMBL7760288 | 0.75 | CHRNB2 (0.55) | SMN1; SMN2RAB9AMEN1KMT2AMAPT | |
| SCHEMBL15778670 | 0.75 | FADS1 (0.68) | P2RX1P2RX4P2RX7FADS1SMN1; SMN2 | |
| SCHEMBL11932152 | 0.75 | P2RX1 (1.00) | P2RX1P2RX4P2RX7FADS1 | |
| SCHEMBL5631068 | 0.75 | P2RX1 (0.77) | P2RX1P2RX4P2RX7FADS1SMN1; SMN2 | |
| SCHEMBL8469266 | 0.74 | SMO (0.56) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL28017780 | 0.72 | SMO (0.55) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL15779338 | 0.72 | NPC1 (0.65) | P2RX1P2RX4P2RX7FADS1SMN1; SMN2 | |
| SCHEMBL2701738 | 0.72 | FADS1 (1.00) | P2RX1P2RX4P2RX7FADS1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2313026-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | Castle Beach, L.L.C. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | Castle Beach, LLC (US) | 2010-02-18 | — | — | US | claimed |
| WO-2010019680-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | HOMOLA ANDREW M (US) | 2010-02-18 | — | — | WO | claimed |
| EP-0805672-B1 | METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH | HOMOLA ANDREW M (US) | 2004-08-25 | — | — | EP | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2025067622-A1 | CANNABIDIOL FOR USE IN ALLEVIATING XEROSTOMIA | FERTIN PHARMA A/S (DK) | 2025-04-03 | — | — | WO | disclosed |
| EP-4088716-B1 | AN ORAL TABLET FOR INDUCED SALIVA GENERATION | FERTIN PHARMA AS (DK) | 2024-10-16 | — | — | EP | disclosed |
| US-11857653-B2 | Method of providing an oral care benefit using a poorly-soluble calcium compound and fluoride | JOHNSON & JOHNSON CONSUMER INC. (US) | 2024-01-02 | — | — | US | disclosed |
| EP-3787604-B1 | A TABLETED CHEWING GUM SUITABLE FOR ACTIVE PHARMACEUTICAL INGREDIENTS | FERTIN PHARMA AS (DK) | 2023-07-05 | — | — | EP | disclosed |
| US-11648186-B2 | Coated particles and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2023-05-16 | — | — | US | disclosed |
| CN-109843255-B | Ethanol-reducing mouthwash formulation | 强生消费者公司 | 2023-02-28 | — | — | CN | disclosed |
| US-5145667-A | Storage stable anticalculus toothpaste, noncationic bactericide, tripolyphosphate | BEECHAM INC. (US) | 1992-09-08 | — | — | US | disclosed |
| WO-1992004007-A1 | COLOR CHANGE MOUTHRINSE | BEECHAM, INCORPORATED (US) | 1992-03-19 | — | — | WO | disclosed |
| US-5032386-A | Dentistry | COLGATE-PALMOLIVE COMPANY (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0161898-B1 | DENTIFRICE COMPOSITIONS | UNILEVER PLC (GB) | 1990-11-07 | — | — | EP | disclosed |
| US-4749562-A | ZINC SALT, ANTIMICROBIAL AGENT, H2O, SURFACTANT MIXED; FORMING LAMELLA LIQUID CRYSTAL PHASE | LEVER BROTHERS COMPANY (US) | 1988-06-07 | — | — | US | disclosed |
| US-4749561-A | ZINC SALT ANTI-PLAQUE AGENT; LIQUID CRYSTAL SURFACTANT PHASE LAMELLA | LEVER BROTHERS COMPANY (US) | 1988-06-07 | — | — | US | disclosed |
| US-4656031-A | SURFACTANT, ABRASIVE AND ANTI-PLAQUE AGENT | LEVER BROTHERS COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0161898-A2 | Dentifrice compositions | UNILEVER PLC (GB) | 1985-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | LIPA, MMP7, CTSA | P2RX1 2757/4885P2RX4 3416/4885P2RX7 2458/4885 |
| US-11648186-B2 | Coated particles and their uses | CD63, EPCAM, CD44 | P2RX1 3481/4885P2RX4 3618/4885P2RX7 3227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.